Accure Therapeutics
Accure Therapeutics is a Barcelona-based neuroscience R&D company developing ACT-02, a novel drug candidate with disease-modifying potential for Parkinson's disease. ACT-02 inhibits Prolyl Endopeptidase (PREP), a promising target in Parkinson's. The company is currently in an advanced preclinical stage.
Buy Funded Startups lists
Funding Round: Grant
Funding Amount: €1.46M
Date: 07-Apr-2025
Investors: The Michael J. Fox Foundation, Luxembourg National Research Fund (FNR)
Markets: Biotechnology, Neuroscience, Pharmaceuticals, HealthTech, Life Sciences
HQ: Barcelona, Catalonia, Spain
Founded: 2020
Website: https://accure.health/
LinkedIn: https://www.linkedin.com/company/accure-therapeutics
Twitter: https://twitter.com/AccureTherapeut
Crunchbase: https://www.crunchbase.com/organization/accure-therapeutics
Leave a Comment
Comments
No comments yet.